Skip to main content

Advertisement

SpringerLink
Log in

Molecular Regulation of JC Virus Tropism: Insights into Potential Therapeutic Targets for Progressive Multifocal Leukoencephalopathy

  • INVITED REVIEW
  • Published:
Journal of Neuroimmune Pharmacology Aims and scope Submit manuscript

Abstract

Progressive multifocal leukoencephalopathy (PML) is a growing concern for patients undergoing immune modulatory therapies for treatment of autoimmune diseases such as multiple sclerosis. Currently, there are no drugs approved for the treatment of PML that have been demonstrated in the patient to effectively and reproducibly alter the course of disease progression. The human polyoma virus JC is the causative agent of PML. JC virus (JCV) dissemination is tightly controlled by regulation of viral gene expression from the promoter by cellular transcription factors expressed in cells permissive for infection. JCV infection likely occurs during childhood, and latent virus containing PML-associated promoter sequences is maintained in lymphoid cells within the bone marrow. Because development of PML is tightly linked to suppression and or modulation of the immune system as in development of hematological malignancies, AIDS, and monoclonal antibody treatments, further scrutiny of the course of JCV infection in immune cells will be essential to our understanding of development of PML and identification of new therapeutic targets.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Aksamit AJ (2001) Treatment of non-AIDS progressive multifocal leukoencephalopathy with cytosine arabinoside. J Neurovirology 7:386–390

    CAS  Google Scholar 

  • Alla P, de Jaureguiberry JP, Gisserot O, Valance J, Jaubert D (2001) Progressive multifocal leucoencephalopathy in a patient with chronic lymphoid leukemia. Presse Med 30:1498–1499

    CAS  PubMed  Google Scholar 

  • Allander T, Andreasson K, Gupta S, Bjerkner A, Bogdanovic G, Persson MA, Dalianis T, Ramqvist T, Andersson B (2007) Identification of a third human polyomavirus. J Virol 81:4130–4136

    CAS  PubMed  Google Scholar 

  • Altschuler EL, Kast RE (2005) The atypical antipsychotic agents ziprasidone [correction of zisprasidone], risperdone and olanzapine as treatment for and prophylaxis against progressive multifocal leukoencephalopathy. Med Hypotheses 65:585–586

    CAS  PubMed  Google Scholar 

  • Amemiya K, Traub R, Durham L, Major EO (1989) Interaction of a nuclear factor-1-like protein with the regulatory region of the human polyomavirus JC virus. J Biol Chem 264:7025–7032

    CAS  PubMed  Google Scholar 

  • Amemiya K, Traub R, Durham L, Major EO (1992) Adjacent nuclear factor-1 and activator protein binding sites in the enhancer of the neurotropic JC virus. A common characteristic of many brain-specific genes. J Biol Chem 267:14204–14211

    CAS  PubMed  Google Scholar 

  • Amemiya K, Durham L, Major EO (1994) Overexpression and reactivation of binding activity of the recombinant CTF/NF-1 transcription factor. Protein Expr Purif 5:57–64

    CAS  PubMed  Google Scholar 

  • Antinori A, De Luca A, Ammassari A, Cingolani A, Murri R, Colosimo G, Roselli R, Scerrati M, Tamburrini E (1994) Failure of cytarabine and increased JC virus-DNA burden in the cerebrospinal fluid of patients with AIDS-related progressive multifocal leucoencephalopathy. AIDS 8:1022–1024

    CAS  PubMed  Google Scholar 

  • Attout H, Rahmeh F, Lehuede G, Girardel M, Ziegler F (2000) Progressive multifocal leukoencephalopathy an chronic lymphocytic leukemia. Rev Med Interne 21:698–700

    CAS  PubMed  Google Scholar 

  • Atwood WJ (2001) A combination of low-dose chlorpromazine and neutralizing antibodies inhibits the spread of JC virus (JCV) in a tissue culture model: implications for prophylactic and therapeutic treatment of progressive multifocal leukoencephalopathy. J Neurovirology 7:307–310

    CAS  Google Scholar 

  • Atwood WJ, Amemiya K, Traub R, Harms J, Major EO (1992) Interaction of the human polyomavirus, JCV, with human B-lymphocytes. Virology 190:716–723

    CAS  PubMed  Google Scholar 

  • Ault GS, Stoner GL (1993) Human polyomavirus JC promoter/enhancer rearrangement patterns from progressive multifocal leukoencephalopathy brain are unique derivatives of a single archetypal structure. J Gen Virol 74:1499–1507

    CAS  PubMed  Google Scholar 

  • Aur JA, Simone JV, Verzosa MS, Hustu HO, Pinkel DP, Barker LF (1978) Leukoencephalopathy in children with acute lymphocytic leukemia receiving preventive central nervous system therapy (author’s transl). Sangre (Barc) 23:1–12

    CAS  Google Scholar 

  • Bagnato F, Pietropoaolo V, Di Taranto C, Lorenzano S, Toni D (2001) Chronic lymphocytic leukemia complicated by progressive multifocal leukoencephalopathy without apparent immunodepression. Eur J Neurol 8:367–368

    CAS  PubMed  Google Scholar 

  • Bar-Or A, Calabresi PA, Arnold D, Markowitz C, Shafer S, Kasper LH, Waubant E, Gazda S, Fox RJ, Panzara M et al (2008) Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, phase I trial. Ann Neurol 63:395–400

    CAS  PubMed  Google Scholar 

  • Baum S, Ashok A, Gee G, Dimitrova S, Querbes W, Jordan J, Atwood WJ (2003) Early events in the life cycle of JC virus as potential therapeutic targets for the treatment of progressive multifocal leukoencephalopathy. J Neurovirology 9(Suppl 1):32–37

    CAS  Google Scholar 

  • Behar A (1965) Progressive multifocal leukoencephalopathy in a case of acute lymphatic leukemia. Isr J Med Sci 1:650–654

    CAS  PubMed  Google Scholar 

  • Biogen (2009) Tysabri update, February 2009

  • Bonig H, Wundes A, Chang KH, Lucas S, Papayannopoulou T (2008) Increased numbers of circulating hematopoietic stem/progenitor cells are chronically maintained in patients treated with the CD49d blocking antibody natalizumab. Blood 111:3439–3441

    CAS  PubMed  Google Scholar 

  • Brickelmaier M, Lugovskoy A, Kartikeyan R, Reviriego-Mendoza MM, Allaire N, Simon K, Frisque RJ, Gorelik L (2009) Identification and characterization of mefloquine efficacy against JC virus in vitro. Antimicrob Agents Chemother 53:1840–1849

    CAS  PubMed  Google Scholar 

  • Buckman R, Wiltshaw E (1976) Letter: progressive multifocal leucoencephalopathy successfully treated with cytosine arabinoside. Br J Haematol 34:153–158

    CAS  PubMed  Google Scholar 

  • Carson KR, Evens AM, Richey EA, Habermann TM, Focosi D, Seymour JF, Laubach J, Bawn SD, Gordon LI, Winter JN et al (2009) Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project. Blood 113:4834–4840

    CAS  PubMed  Google Scholar 

  • Cather JC, Menter A (2003) Modulating T cell responses for the treatment of psoriasis: a focus on efalizumab. Expert Opin Biol Ther 3:361–370

    CAS  PubMed  Google Scholar 

  • Chang CF, Gallia GL, Muralidharan V, Chen NN, Zoltick P, Johnson E, Khalili K (1996) Evidence that replication of human neurotropic JC virus DNA in glial cells is regulated by the sequence-specific single-stranded DNA-binding protein Pur alpha. J Virol 70:4150–4156

    CAS  PubMed  Google Scholar 

  • Chapagain ML, Sumibcay L, Gurjav U, Kaufusi PH, Kast RE, Nerurkar VR (2008) Serotonin receptor 2A blocker (risperidone) has no effect on human polyomavirus JC infection of primary human fetal glial cells. J Neurovirology 14:448–454

    CAS  Google Scholar 

  • Chen NN, Khalili K (1995) Transcriptional regulation of human JC polyomavirus promoters by cellular proteins YB-1 and Pur alpha in glial cells. J Virol 69:5843–5848

    CAS  PubMed  Google Scholar 

  • Chen NN, Chang CF, Gallia GL, Kerr DA, Johnson EM, Krachmarov CP, Barr SM, Frisque RJ, Bollag B, Khalili K (1995) Cooperative action of cellular proteins YB-1 and Pur alpha with the tumor antigen of the human JC polyomavirus determines their interaction with the viral lytic control element. Proc Natl Acad Sci USA 92:1087–1091

    CAS  PubMed  Google Scholar 

  • Chen NN, Kerr D, Chang CF, Honjo T, Khalili K (1997) Evidence for regulation of transcription and replication of the human neurotropic virus JCV genome by the human S(mu)bp-2 protein in glial cells. Gene 185:55–62

    CAS  PubMed  Google Scholar 

  • Chen Y, Bord E, Tompkins T, Miller J, Tan CS, Kinkel RP, Stein MC, Viscidi RP, Ngo LH, Koralnik IJ (2009) Asymptomatic reactivation of JC virus in patients treated with natalizumab. N Engl J Med 361:1067–1074

    CAS  PubMed  Google Scholar 

  • Chesters PM, Heritage J, McCance DJ (1983) Persistence of DNA sequences of BK virus and JC virus in normal human tissues and in diseased tissues. J Infect Dis 147:676–684

    CAS  PubMed  Google Scholar 

  • Cid J, Revilla M, Cervera A, Cervantes F, Munoz E, Ferrer I, Montserrat E (2000) Progressive multifocal leukoencephalopathy following oral fludarabine treatment of chronic lymphocytic leukemia. Ann Hematol 79:392–395

    CAS  PubMed  Google Scholar 

  • Conomy JP, Beard NS, Matsumoto H, Roessmann U (1974) Cytarabine treatment of progressive multifocal leukoencephalopathy. Clinical course and detection of virus-like particles after antiviral chemotherapy. JAMA 229:1313–1316

    CAS  PubMed  Google Scholar 

  • Coppo P, Laporte JP, Aoudjhane M, Lebon P, Isnard F, Lesage S, Gorin NC, Najman A (1999) Progressive multifocal leucoencephalopathy with peripheral demyelinating neuropathy after autologous bone marrow transplantation for acute myeloblastic leukemia (FAB5). Bone Marrow Transplant 23:401–403

    CAS  PubMed  Google Scholar 

  • Cree BA, Lamb S, Morgan K, Chen A, Waubant E, Genain C (2005) An open label study of the effects of rituximab in neuromyelitis optica. Neurology 64:1270–1272

    CAS  PubMed  Google Scholar 

  • Dalianis T, Ramqvist T, Andreasson K, Kean JM, Garcea RL (2009) KI, WU and Merkel cell polyomaviruses: a new era for human polyomavirus research. Semin Cancer Biol 19:270–275

    CAS  PubMed  Google Scholar 

  • Daniel AM, Frisque RJ (1993) Transcription initiation sites of prototype and variant JC virus early and late messenger RNAs. Virology 194:97–109

    CAS  PubMed  Google Scholar 

  • Daniel AM, Swenson JJ, Mayreddy RP, Khalili K, Frisque RJ (1996) Sequences within the early and late promoters of archetype JC virus restrict viral DNA replication and infectivity. Virology 216:90–101

    CAS  PubMed  Google Scholar 

  • De Clercq E (2009) Another ten stories in antiviral drug discovery (part C): “old” and “new” antivirals, strategies, and perspectives. Med Res Rev 29:611–645

    PubMed  Google Scholar 

  • de Latour RP, Chaoui D, Bourhis JH, Belhocine R, Park S, Legrand O, Brault P, Rio B, Heshmati F, Assouad S et al (2007) Mobilization of peripheral blood progenitor cells after DHAP regimen with or without rituximab: a large multicenter comparative study in patients with malignant lymphoma. Leuk Lymphoma 48:897–904

    PubMed  Google Scholar 

  • De Luca A, Giancola ML, Cingolani A, Ammassari A, Gillini L, Murri R, Antinori A (1999) Clinical and virological monitoring during treatment with intrathecal cytarabine in patients with AIDS-associated progressive multifocal leukoencephalopathy. Clin Infect Dis 28:624–628

    PubMed  Google Scholar 

  • Dorries K, ter Meulen V (1983) Progressive multifocal leucoencephalopathy: detection of papovavirus JC in kidney tissue. J Med Virol 11:307–317

    CAS  PubMed  Google Scholar 

  • Dorries K, Vogel E, Gunther S, Czub S (1994) Infection of human polyomaviruses JC and BK in peripheral blood leukocytes from immunocompetent individuals. Virology 198:59–70

    CAS  PubMed  Google Scholar 

  • Egli A, Infanti L, Dumoulin A, Buser A, Samaridis J, Stebler C, Gosert R, Hirsch HH (2009) Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. J Infect Dis 199:837–846

    CAS  PubMed  Google Scholar 

  • Elphick GF, Querbes W, Jordan JA, Gee GV, Eash S, Manley K, Dugan A, Stanifer M, Bhatnagar A, Kroeze WK et al (2004) The human polyomavirus, JCV, uses serotonin receptors to infect cells. Science 306:1380–1383

    CAS  PubMed  Google Scholar 

  • Engelhardt B, Kappos L (2008) Natalizumab: targeting alpha4-integrins in multiple sclerosis. Neurodegener Dis 5:16–22

    CAS  PubMed  Google Scholar 

  • Erselius JR, Jostes B, Hatzopoulos AK, Mosthaf L, Gruss P (1990) Cell-type-specific control elements of the lymphotropic papovavirus enhancer. J Virol 64:1657–1666

    CAS  PubMed  Google Scholar 

  • Fanale MA, Younes A (2007) Monoclonal antibodies in the treatment of non-Hodgkin’s lymphoma. Drugs 67:333–350

    CAS  PubMed  Google Scholar 

  • Farge D, Herve R, Mikol J, Sauvaget F, Ingrand D, Singer B, Ferchal F, Auperin I, Gray F, Sudaka A et al (1994) Simultaneous progressive multifocal leukoencephalopathy, Epstein–Barr virus (EBV) latent infection and cerebral parenchymal infiltration during chronic lymphocytic leukemia. Leukemia 8:318–321

    CAS  PubMed  Google Scholar 

  • Feng H, Shuda M, Chang Y, Moore PS (2008) Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 319:1096–1100

    CAS  PubMed  Google Scholar 

  • Fiers W, Contreras R, Haegemann G, Rogiers R, Van de Voorde A, Van Heuverswyn H, Van Herreweghe J, Volckaert G, Ysebaert M (1978) Complete nucleotide sequence of SV40 DNA. Nature 273:113–120

    CAS  PubMed  Google Scholar 

  • Flaegstad T, Sundsfjord A, Arthur RR, Pedersen M, Traavik T, Subramani S (1991) Amplification and sequencing of the control regions of BK and JC virus from human urine by polymerase chain reaction. Virology 180:553–560

    CAS  PubMed  Google Scholar 

  • Flanagan P, Costello C (1989) Progressive multifocal leucoencephalopathy in patients with chronic lymphocytic leukaemia. Clin Lab Haematol 11:78–79

    CAS  PubMed  Google Scholar 

  • Frampton JE, Plosker GL (2009) Efalizumab: a review of its use in the management of chronic moderate-to-severe plaque psoriasis. Am J Clin Dermatol 10:51–72

    PubMed  Google Scholar 

  • Freim Wahl SG, Folvik MR, Torp SH (2007) Progressive multifocal leukoencephalopathy in a lymphoma patient with complete remission after treatment with cytostatics and rituximab: case report and review of the literature. Clin Neuropathol 26:68–73

    CAS  PubMed  Google Scholar 

  • Frisque RJ (1983a) Nucleotide sequence of the region encompassing the JC virus origin of DNA replication. J Virol 46:170–176

    CAS  PubMed  Google Scholar 

  • Frisque RJ (1983b) Regulatory sequences and virus–cell interactions of JC virus. Prog Clin Biol Res 105:41–59

    CAS  PubMed  Google Scholar 

  • Frisque RJ, Bream GL, Cannella MT (1984) Human polyomavirus JC virus genome. J Virol 51:458–469

    CAS  PubMed  Google Scholar 

  • Ganguly S, Ganguly SB, Biswas K (1995) Progressive multifocal leukoencephalopathy in a case of acute lymphocytic leukemia. Indian Pediatr 32:684–686

    CAS  PubMed  Google Scholar 

  • Garrels K, Kucharczyk W, Wortzman G, Shandling M (1996) Progressive multifocal leukoencephalopathy: clinical and MR response to treatment. AJNR Am J Neuroradiol 17:597–600

    CAS  PubMed  Google Scholar 

  • Garvey B (2008) Rituximab in the treatment of autoimmune haematological disorders. Br J Haematol 141:149–169

    CAS  PubMed  Google Scholar 

  • Gay CT, Bodensteiner JB, Nitschke R, Sexauer C, Wilson D (1989) Reversible treatment-related leukoencephalopathy. J Child Neurol 4:208–213

    CAS  PubMed  Google Scholar 

  • Gaynor AM, Nissen MD, Whiley DM, Mackay IM, Lambert SB, Wu G, Brennan DC, Storch GA, Sloots TP, Wang D (2007) Identification of a novel polyomavirus from patients with acute respiratory tract infections. PLoS Pathog 3:e64

    PubMed  Google Scholar 

  • GiaRusso MH, Koeppen AH (1978) Atypical progressive multifocal leukoencephalopathy and primary cerebral malignant lymphoma. J Neurol Sci 35:391–398

    CAS  PubMed  Google Scholar 

  • Goldberg SL, Pecora AL, Alter RS, Kroll MS, Rowley SD, Waintraub SE, Imrit K, Preti RA (2002) Unusual viral infections (progressive multifocal leukoencephalopathy and cytomegalovirus disease) after high-dose chemotherapy with autologous blood stem cell rescue and peritransplantation rituximab. Blood 99:1486–1488

    CAS  PubMed  Google Scholar 

  • Grillo-Lopez AJ, White CA, Dallaire BK, Varns CL, Shen CD, Wei A, Leonard JE, McClure A, Weaver R, Cairelli S et al (2000) Rituximab: the first monoclonal antibody approved for the treatment of lymphoma. Curr Pharm Biotechnol 1:1–9

    CAS  PubMed  Google Scholar 

  • Grinnell BW, Padgett BL, Walker DL (1983) Distribution of nonintegrated DNA from JC papovavirus in organs of patients with progressive multifocal leukoencephalopathy. J Infect Dis 147:669–675

    CAS  PubMed  Google Scholar 

  • Gronostajski RM (2000) Roles of the NFI/CTF gene family in transcription and development. Gene 249:31–45

    CAS  PubMed  Google Scholar 

  • Gronostajski RM, Adhya S, Nagata K, Guggenheimer RA, Hurwitz J (1985) Site-specific DNA binding of nuclear factor I: analyses of cellular binding sites. Mol Cell Biol 5:964–971

    CAS  PubMed  Google Scholar 

  • Hall CD, Dafni U, Simpson D, Clifford D, Wetherill PE, Cohen B, McArthur J, Hollander H, Yainnoutsos C, Major E et al (1998) Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team. N Engl J Med 338:1345–1351

    CAS  PubMed  Google Scholar 

  • Hamadani M, Awan FT (2009) Remission induction, consolidation and novel agents in development for adults with acute myeloid leukaemia. Hematol Oncol 28:3–12

    Google Scholar 

  • Happe S, Besselmann M, Matheja P, Rickert CH, Schuierer G, Reichelt D, Husstedt IW (1999) Cidofovir (vistide) in therapy of progressive multifocal leukoencephalopathy in AIDS. Review of the literature and report of 2 cases. Nervenarzt 70:935–943

    CAS  PubMed  Google Scholar 

  • Hartung HP (2009) New cases of progressive multifocal leukoencephalopathy after treatment with natalizumab. Lancet Neurol 8:28–31

    PubMed  Google Scholar 

  • Hasan MM, Taylor P (2005) Progressive multifocal leucoencephalopathy in a case of chronic lymphocytic leukaemia. Br J Haematol 130:808

    PubMed  Google Scholar 

  • Hauser SL, Waubant E, Arnold DL, Vollmer T, Antel J, Fox RJ, Bar-Or A, Panzara M, Sarkar N, Agarwal S et al (2008) B-cell depletion with rituximab in relapsing–remitting multiple sclerosis. N Engl J Med 358:676–688

    CAS  PubMed  Google Scholar 

  • Heide W, Kompf D, Reusche E, Bodemer M, Weber T (1995) Failure of cytarabine/interferon therapy in progressive multifocal leukoencephalopathy. Ann Neurol 37:412–413

    CAS  PubMed  Google Scholar 

  • Heikens J, van Berkel W, de Vos RA, van der Avoort HG, Krul MR (1992) Progressive multifocal leukoencephalopathy in a female patient with chronic lymphatic leukemia. Ned Tijdschr Geneeskd 136:232–235

    CAS  PubMed  Google Scholar 

  • Hennighausen L, Siebenlist U, Danner D, Leder P, Rawlins D, Rosenfeld P, Kelly T Jr (1985) High-affinity binding site for a specific nuclear protein in the human IgM gene. Nature 314:289–292

    CAS  PubMed  Google Scholar 

  • Henson JW (1994) Regulation of the glial-specific JC virus early promoter by the transcription factor Sp1. J Biol Chem 269:1046–1050

    CAS  PubMed  Google Scholar 

  • Henson J, Saffer J, Furneaux H (1992) The transcription factor Sp1 binds to the JC virus promoter and is selectively expressed in glial cells in human brain. Ann Neurol 32:72–77

    CAS  PubMed  Google Scholar 

  • Hofeler H, Popescu O, Gunther B, Schmidt U, Hornung G, Hoffken K, Schmidt CG (1987) Progressive multifocal leukoencephalopathy. Late complication in chronic lymphatic leukemia. Dtsch Med Wochenschr 112:963–966

    CAS  PubMed  Google Scholar 

  • Hogan TF, Borden EC, McBain JA, Padgett BL, Walker DL (1980) Human polyomavirus infections with JC virus and BK virus in renal transplant patients. Ann Intern Med 92:373–378

    CAS  PubMed  Google Scholar 

  • Horn GV, Bastian FO, Moake JL (1978) Progressive multifocal leukoencephalopathy: failure of response to transfer factor and cytarabine. Neurology 28:794–797

    CAS  PubMed  Google Scholar 

  • Hou J, Major EO (1998) The efficacy of nucleoside analogs against JC virus multiplication in a persistently infected human fetal brain cell line. J Neurovirology 4:451–456

    CAS  Google Scholar 

  • Houff SA, Major EO, Katz DA, Kufta CV, Sever JL, Pittaluga S, Roberts JR, Gitt J, Saini N, Lux W (1988) Involvement of JC virus-infected mononuclear cells from the bone marrow and spleen in the pathogenesis of progressive multifocal leukoencephalopathy. N Engl J Med 318:301–305

    CAS  PubMed  Google Scholar 

  • Hwang TL, Yung WK, Lee YY, Borit A, Fields WS (1986) High dose Ara-C related leukoencephalopathy. J Neuro-oncol 3:335–339

    CAS  Google Scholar 

  • IDEC B (2008) Biogen IDEC, Inc. Q2 2008 Earnings call transcript. Biogen IDEC, Cambridge

    Google Scholar 

  • Iida T, Kitamura T, Guo J, Taguchi F, Aso Y, Nagashima K, Yogo Y (1993) Origin of JC polyomavirus variants associated with progressive multifocal leukoencephalopathy. Proc Natl Acad Sci USA 90:5062–5065

    CAS  PubMed  Google Scholar 

  • Jacquerioz FA, Croft AM (2009) Drugs for preventing malaria in travellers. Cochrane Database Syst Rev (Issue 4):Art. No. CD006491

  • Jensen PN, Major EO (1999) Viral variant nucleotide sequences help expose leukocytic positioning in the JC virus pathway to the CNS. J Leukoc Biol 65:428–438

    CAS  PubMed  Google Scholar 

  • Jones R, Kunsman G, Levine B, Smith M, Stahl C (1994) Mefloquine distribution in postmortem cases. Forensic Sci Int 68:29–32

    CAS  PubMed  Google Scholar 

  • Kenney S, Natarajan V, Salzman NP (1986) Mapping 5’ termini of JC virus late RNA. J Virol 58:216–219

    CAS  PubMed  Google Scholar 

  • Kerr D, Chang CF, Chen N, Gallia G, Raj G, Schwartz B, Khalili K (1994) Transcription of a human neurotropic virus promoter in glial cells: effect of YB-1 on expression of the JC virus late gene. J Virol 68:7637–7643

    CAS  PubMed  Google Scholar 

  • Kesari S, Akar S, Saad A, Drappatz J, Koralnik IJ, DeAngelo DJ (2008) Progressive multifocal leukoencephalopathy in a patient with relapsed acute myelogenous leukemia. J Clin Oncol 26:3804–3807

    PubMed  Google Scholar 

  • Khalili K, Khoury G, Brady J (1986) Spacing between simian virus 40 early transcriptional control sequences is important for regulation of early RNA synthesis and gene expression. J Virol 60:935–942

    CAS  PubMed  Google Scholar 

  • Kiewe P, Seyfert S, Korper S, Rieger K, Thiel E, Knauf W (2003) Progressive multifocal leukoencephalopathy with detection of JC virus in a patient with chronic lymphocytic leukemia parallel to onset of fludarabine therapy. Leuk Lymphoma 44:1815–1818

    PubMed  Google Scholar 

  • Kim J, Woolridge S, Biffi R, Borghi E, Lassak A, Ferrante P, Amini S, Khalili K, Safak M (2003) Members of the AP-1 family, c-Jun and c-Fos, functionally interact with JC virus early regulatory protein large T antigen. J Virol 77:5241–5252

    CAS  PubMed  Google Scholar 

  • Kim SY, Choi EC, Woo Jo Y, Henson JW, Kim HS (2004) Transcriptional activation of JC virus early promoter by phorbol ester and interleukin-1beta: critical role of nuclear factor-1. Virology 327:60–69

    CAS  PubMed  Google Scholar 

  • Kim SY, Kim DH, Hyun JW, Henson JW, Kim HS (2006) Irisolidone, an isoflavone metabolite, represses JC virus gene expression via inhibition of Sp1 binding in human glial cells. Biochem Biophys Res Commun 344:3–8

    CAS  PubMed  Google Scholar 

  • Kleinschmidt-DeMasters BK, Tyler KL (2005) Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. N Engl J Med 353:369–374

    CAS  PubMed  Google Scholar 

  • Krebs CJ, McAvoy MT, Kumar G (1995) The JC virus minimal core promoter is glial cell specific in vivo. J Virol 69:2434–2442

    CAS  PubMed  Google Scholar 

  • Krumbholz M, Meinl I, Kumpfel T, Hohlfeld R, Meinl E (2008) Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis. Neurology 71:1350–1354

    CAS  PubMed  Google Scholar 

  • Kumar KU, Pater A, Pater MM (1993) Human JC virus perfect palindromic nuclear factor 1-binding sequences important for glial cell-specific expression in differentiating embryonal carcinoma cells. J Virol 67:572–576

    CAS  PubMed  Google Scholar 

  • Kumar KU, Devireddy LR, Tang SC, Pater A, Pater MM (1996) Human JC virus nuclear factor 1 binding motifs and large tumor antigen region required for transactivation of late promoter. J Neurochem 67:473–481

    CAS  PubMed  Google Scholar 

  • Langer-Gould A, Atlas SW, Green AJ, Bollen AW, Pelletier D (2005) Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N Engl J Med 353:375–381

    CAS  PubMed  Google Scholar 

  • Law MF, Martin JD, Takemoto KK, Howley PM (1979) The colinear alignment of the genomes of papovaviruses JC, BK, and SV40. Virology 96:576–587

    CAS  PubMed  Google Scholar 

  • Leandro MJ, Cambridge G, Ehrenstein MR, Edwards JC (2006) Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritis. Arthritis Rheum 54:613–620

    CAS  PubMed  Google Scholar 

  • Leegwater PA, Van Driel W, van der Vliet PC (1985) Recognition site of nuclear factor I, a sequence-specific DNA-binding protein from HeLa cells that stimulates adenovirus DNA replication. EMBO J 4:1515–1521

    CAS  PubMed  Google Scholar 

  • Leger H, Sock E, Renner K, Grummt F, Wegner M (1995) Functional interaction between the POU domain protein Tst-1/Oct-6 and the high-mobility-group protein HMG-I/Y. Mol Cell Biol 15:3738–3747

    CAS  PubMed  Google Scholar 

  • Leonard S, Hulin C, Anxionnat R, Grignon Y, Taillandier L, Vespignani H (2002) Multifocal progressive leukoencephalitis in a patient given fludarabine for chronic lymphoid leukemia. Rev Neurol (Paris) 158:1121–1123

    CAS  Google Scholar 

  • Levy RM, Major E, Ali MJ, Cohen B, Groothius D (2001) Convection-enhanced intraparenchymal delivery (CEID) of cytosine arabinoside (AraC) for the treatment of HIV-related progressive multifocal leukoencephalopathy (PML). J Neurovirology 7:382–385

    CAS  Google Scholar 

  • Linda H, von Heijne A, Major EO, Ryschkewitsch C, Berg J, Olsson T, Martin C (2009) Progressive multifocal leukoencephalopathy after natalizumab monotherapy. N Engl J Med 361:1081–1087

    CAS  PubMed  Google Scholar 

  • Lindberg RL, Achtnichts L, Hoffmann F, Kuhle J, Kappos L (2008) Natalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patients. J Neuroimmunol 194:153–164

    CAS  PubMed  Google Scholar 

  • Linker RA, Kieseier BC, Gold R (2008) Identification and development of new therapeutics for multiple sclerosis. Trends Pharmacol Sci 29:558–565

    CAS  PubMed  Google Scholar 

  • Liu CK, Wei G, Atwood WJ (1998) Infection of glial cells by the human polyomavirus JC is mediated by an N-linked glycoprotein containing terminal alpha(2-6)-linked sialic acids. J Virol 72:4643–4649

    CAS  PubMed  Google Scholar 

  • Loeber G, Dorries K (1988) DNA rearrangements in organ-specific variants of polyomavirus JC strain GS. J Virol 62:1730–1735

    CAS  PubMed  Google Scholar 

  • Major EO (2009) Reemergence of PML in natalizumab-treated patients—new cases, same concerns. N Engl J Med 361:1041–1043

    CAS  PubMed  Google Scholar 

  • Major EO (2010) Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies. Annu Rev Med 61:8.1–8.13

    Google Scholar 

  • Major EO, Amemiya K, Elder G, Houff SA (1990) Glial cells of the human developing brain and B cells of the immune system share a common DNA binding factor for recognition of the regulatory sequences of the human polyomavirus, JCV. J Neurosci Res 27:461–471

    CAS  PubMed  Google Scholar 

  • Malkoun I, Vidry E, Revenco E, Drobacheff MC, Berger E, Rumbach L (2006) Role of immunity in the development of progressive multifocal leukoencephalopathy: a report of three patients with type B lymphoma and humoral immunodeficiency and six others with acquired immunodeficiency syndrome. Rev Neurol (Paris) 162:82–88

    CAS  Google Scholar 

  • Maloney DG, Grillo-Lopez AJ, White CA, Bodkin D, Schilder RJ, Neidhart JA, Janakiraman N, Foon KA, Liles TM, Dallaire BK et al (1997) IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin’s lymphoma. Blood 90:2188–2195

    CAS  PubMed  Google Scholar 

  • Manley K, O’Hara BA, Gee GV, Simkevich CP, Sedivy JM, Atwood WJ (2006) NFAT4 is required for JC virus infection of glial cells. J Virol 80:12079–12085

    CAS  PubMed  Google Scholar 

  • Marriott PJ, O’Brien MD, Mackenzie IC, Janota I (1975) Progressive multifocal leucoencephalopathy: remission with cytarabine. J Neurol Neurosurg Psychiatry 38:205–209

    CAS  PubMed  Google Scholar 

  • Marshall LJ, Ryschkewitsch C, Jensen PN, Major EO (2009) Acquisition of unique Spi-B binding sites in the JC virus promoter: a potential susceptibility factor for development of progressive multifocal leukoencephalopathy. Presented at Am Soc Virol Annu Meet, 28th, Vancouver, Canada

  • Martin JD, King DM, Slauch JM, Frisque RJ (1985) Differences in regulatory sequences of naturally occurring JC virus variants. J Virol 53:306–311

    CAS  PubMed  Google Scholar 

  • Marzocchetti A, Wuthrich C, Tan CS, Tompkins T, Bernal-Cano F, Bhargava P, Ropper AH, Koralnik IJ (2008) Rearrangement of the JC virus regulatory region sequence in the bone marrow of a patient with rheumatoid arthritis and progressive multifocal leukoencephalopathy. J Neurovirology 14:455–458

    CAS  Google Scholar 

  • Mata MI, Gardella S, del Mar CM, Ortiz MR (2000) Progressive multifocal leukoencephalopathy in a patient with chronic lymphatic leukemia treated with fludarabine. Med Clin (Barc) 115:598–599

    CAS  Google Scholar 

  • Matsuo T, Kyoraku I, Shiomi K, Sugimoto S, Zheng HY, Nakazato M (2007) Detection of novel rearrangement of the JC virus gene in a case of progressive multifocal leukoencephalopathy with adult T-cell leukemia. Rinsho Shinkeigaku 47:27–31

    PubMed  Google Scholar 

  • Mayreddy RP, Safak M, Razmara M, Zoltick P, Khalili K (1996) Transcription of the JC virus archetype late genome: importance of the kappa B and the 23-base-pair motifs in late promoter activity in glial cells. J Virol 70:2387–2393

    CAS  PubMed  Google Scholar 

  • Messam CA, Hou J, Gronostajski RM, Major EO (2003) Lineage pathway of human brain progenitor cells identified by JC virus susceptibility. Ann Neurol 53:636–646

    CAS  PubMed  Google Scholar 

  • Mischitelli M, Fioriti D, Videtta M, Degener AM, Antinori A, Cinque P, Giordano A, Pietropaolo V (2005) Investigation on the role of cell transcriptional factor Sp1 and HIV-1 TAT protein in PML onset or development. J Cell Physiol 204:913–918

    CAS  PubMed  Google Scholar 

  • Monaco MC, Major EO (2009) Culture of human fetal brain progenitor derived oligodendrocytes. National Institute of Neurological Disease and Stroke, National Institutes of Health, Bethesda

    Google Scholar 

  • Monaco MC, Atwood WJ, Gravell M, Tornatore CS, Major EO (1996) JC virus infection of hematopoietic progenitor cells, primary B lymphocytes, and tonsillar stromal cells: implications for viral latency. J Virol 70:7004–7012

    CAS  PubMed  Google Scholar 

  • Monaco MC, Jensen PN, Hou J, Durham LC, Major EO (1998) Detection of JC virus DNA in human tonsil tissue: evidence for site of initial viral infection. J Virol 72:9918–9923

    CAS  PubMed  Google Scholar 

  • Monaco MC, Sabath BF, Durham LC, Major EO (2001) JC virus multiplication in human hematopoietic progenitor cells requires the NF-1 class D transcription factor. J Virol 75:9687–9695

    CAS  PubMed  Google Scholar 

  • Monson NL, Cravens PD, Frohman EM, Hawker K, Racke MK (2005) Effect of rituximab on the peripheral blood and cerebrospinal fluid B cells in patients with primary progressive multiple sclerosis. Arch Neurol 62:258–264

    PubMed  Google Scholar 

  • Moreno S, Miralles P, Diaz MD, Berenguer J, Bernaldo de Quiros JC, Blazquez R, Cosin J, Bouza E (1996) Cytarabine therapy for progressive multifocal leukoencephalopathy in patients with AIDS. Clin Infect Dis 23:1066–1068

    CAS  PubMed  Google Scholar 

  • Neff RT, Hurst FP, Falta EM, Bohen EM, Lentine KL, Dharnidharka VR, Agodoa LY, Jindal RM, Yuan CM, Abbott KC (2008) Progressive multifocal leukoencephalopathy and use of mycophenolate mofetil after kidney transplantation. Transplantation 86:1474–1478

    PubMed  Google Scholar 

  • Nicoli F, Chave B, Peragut JC, Gastaut JL (1992) Efficacy of cytarabine in progressive multifocal leucoencephalopathy in AIDS. Lancet 339:306

    CAS  PubMed  Google Scholar 

  • Nowak-Michalska T, Barcikowska M, Kida E, Budka H, Liberski PP (1993) A case of progressive multifocal leucoencephalopathy during chronic lymphocytic leukaemia. Neurol Neurochir Pol 27:905–912

    CAS  PubMed  Google Scholar 

  • Nowock J, Borgmeyer U, Puschel AW, Rupp RA, Sippel AE (1985) The TGGCA protein binds to the MMTV-LTR, the adenovirus origin of replication, and the BK virus enhancer. Nucleic Acids Res 13:2045–2061

    CAS  PubMed  Google Scholar 

  • O’Riordan T, Daly PA, Hutchinson M, Shattock AG, Gardner SD (1990) Progressive multifocal leukoencephalopathy-remission with cytarabine. J Infect 20:51–54

    PubMed  Google Scholar 

  • Pelosini M, Focosi D, Rita F, Galimberti S, Caracciolo F, Benedetti E, Papineschi F, Petrini M (2008) Progressive multifocal leukoencephalopathy: report of three cases in HIV-negative hematological patients and review of literature. Ann Hematol 87:405–412

    PubMed  Google Scholar 

  • Pettersson M, Schaffner W (1987) A purine-rich DNA sequence motif present in SV40 and lymphotropic papovavirus binds a 1ymphoid-specific factor and contributes to enhancer activity in 1ymphoid ce11s. Genes Dev 1:962–972

    CAS  Google Scholar 

  • Pham YT, Nosten F, Farinotti R, White NJ, Gimenez F (1999) Cerebral uptake of mefloquine enantiomers in fatal cerebral malaria. Int J Clin Pharmacol Ther 37:58–61

    CAS  PubMed  Google Scholar 

  • Pina-Oviedo S, Khalili K, Del Valle L (2009) Hypoxia inducible factor-1 alpha activation of the JCV promoter: role in the pathogenesis of progressive multifocal leukoencephalopathy. Acta Neuropathol 118:235–247

    CAS  PubMed  Google Scholar 

  • Pohlmann C, Hochauf K, Rollig C, Schetelig J, Wunderlich O, Bandt D, Ehninger G, Jacobs E, Rohayem J (2007) Chlorpromazine combined with cidofovir for treatment of a patient suffering from progressive multifocal leukoencephalopathy. Intervirology 50:412–417

    PubMed  Google Scholar 

  • Portegies P, Algra PR, Hollak CE, Prins JM, Reiss P, Valk J, Lange JM (1991) Response to cytarabine in progressive multifocal leucoencephalopathy in AIDS. Lancet 337:680–681

    CAS  PubMed  Google Scholar 

  • Przepiorka D, Jaeckle KA, Birdwell RR, Fuller GN, Kumar AJ, Huh YO, McCutcheon I (1997) Successful treatment of progressive multifocal leukoencephalopathy with low-dose interleukin-2. Bone Marrow Transplant 20:983–987

    CAS  PubMed  Google Scholar 

  • Ramos-Casals M, Soto MJ, Cuadrado MJ, Khamashta MA (2009) Rituximab in systemic lupus erythematosus: a systematic review of off-label use in 188 cases. Lupus 18:767–776

    CAS  PubMed  Google Scholar 

  • Rand KH, Johnson KP, Rubinstein LJ, Wolinsky JS, Penney JB, Walker DL, Padgett BL, Merigan TC (1977) Adenine arabinoside in the treatment of progressive multifocal leukoencephalopathy: use of virus-containing cells in the urine to assess response to therapy. Ann Neurol 1:458–462

    CAS  PubMed  Google Scholar 

  • Ranganathan PN, Khalili K (1993) The transcriptional enhancer element, kappa B, regulates promoter activity of the human neurotropic virus, JCV, in cells derived from the CNS. Nucleic Acids Res 21:1959–1964

    CAS  PubMed  Google Scholar 

  • Ravichandran V, Major EO (2008) DNA-binding transcription factor NF-1A negatively regulates JC virus multiplication. J Gen Virol 89:1396–1401

    CAS  PubMed  Google Scholar 

  • Ravichandran V, Sabath BF, Jensen PN, Houff SA, Major EO (2006) Interactions between c-Jun, nuclear factor 1, and JC virus promoter sequences: implications for viral tropism. J Virol 80:10506–10513

    CAS  PubMed  Google Scholar 

  • Reddy VB, Thimmappaya B, Dhar R, Subramanian KN, Zain BS, Pan J, Ghosh PK, Celma ML, Weissman SM (1978) The genome of simian virus 40. Science 200:494–502

    CAS  PubMed  Google Scholar 

  • Renner K, Sock E, Bermingham JR Jr, Wegner M (1996a) Expression of the gene for the POU domain transcription factor Tst-1/Oct6 is regulated by an estrogen-dependent enhancer. Nucleic Acids Res 24:4552–4557

    CAS  PubMed  Google Scholar 

  • Renner K, Sock E, Gerber JK, Wegner M (1996b) T antigen of human papovavirus JC stimulates transcription of the POU domain factor Tst-1/Oct6/SCIP. DNA Cell Biol 15:1057–1062

    CAS  PubMed  Google Scholar 

  • Rice GP, Hartung HP, Calabresi PA (2005) Anti-alpha4 integrin therapy for multiple sclerosis: mechanisms and rationale. Neurology 64:1336–1342

    CAS  PubMed  Google Scholar 

  • Robb J, Chalmers L, Rojiani A, Chamberlain M (2006) Multifocal necrotizing leukoencephalopathy: an unusual complication of acute leukemia. Arch Neurol 63:1028–1029

    PubMed  Google Scholar 

  • Roll P, Palanichamy A, Kneitz C, Dorner T, Tony HP (2006) Regeneration of B cell subsets after transient B cell depletion using anti-CD20 antibodies in rheumatoid arthritis. Arthritis Rheum 54:2377–2386

    CAS  PubMed  Google Scholar 

  • Roll P, Dorner T, Tony HP (2008) Anti-CD20 therapy in patients with rheumatoid arthritis: predictors of response and B cell subset regeneration after repeated treatment. Arthritis Rheum 58:1566–1575

    CAS  PubMed  Google Scholar 

  • Romagnoli L, Sariyer IK, Tung J, Feliciano M, Sawaya BE, Del Valle L, Ferrante P, Khalili K, Safak M, White MK (2008) Early growth response-1 protein is induced by JC virus infection and binds and regulates the JC virus promoter. Virology 375:331–341

    CAS  PubMed  Google Scholar 

  • Romagnoli L, Wollebo HS, Deshmane SL, Mukerjee R, Del Valle L, Safak M, Khalili K, White MK (2009) Modulation of JC virus transcription by C/EBPbeta. Virus Res 146:97–106

    CAS  PubMed  Google Scholar 

  • Rommer PS, Stuve O, Goertsches R, Mix E, Zettl UK (2008) Monoclonal antibodies in the therapy of multiple sclerosis: an overview. J Neurol 255(Suppl 6):28–35

    CAS  PubMed  Google Scholar 

  • Sadowska B, Barrucco R, Khalili K, Safak M (2003) Regulation of human polyomavirus JC virus gene transcription by AP-1 in glial cells. J Virol 77:665–672

    CAS  PubMed  Google Scholar 

  • Safak M, Khalili K (2001) Physical and functional interaction between viral and cellular proteins modulate JCV gene transcription. J Neurovirology 7:288–292

    CAS  Google Scholar 

  • Safak M, Gallia GL, Ansari SA, Khalili K (1999) Physical and functional interaction between the Y-box binding protein YB-1 and human polyomavirus JC virus large T antigen. J Virol 73:10146–10157

    CAS  PubMed  Google Scholar 

  • Safak M, Sadowska B, Barrucco R, Khalili K (2002) Functional interaction between JC virus late regulatory agnoprotein and cellular Y-box binding transcription factor, YB-1. J Virol 76:3828–3838

    CAS  PubMed  Google Scholar 

  • Saumoy M, Castells G, Escoda L, Mares R, Richart C, Ugarriza A (2002) Progressive multifocal leukoencephalopathy in chronic lymphocytic leukemia after treatment with fludarabine. Leuk Lymphoma 43:433–436

    PubMed  Google Scholar 

  • Schaumburg C, O’Hara BA, Lane TE, Atwood WJ (2008) Human embryonic stem cell-derived oligodendrocyte progenitor cells express the serotonin receptor and are susceptible to JC virus infection. J Virol 82:8896–8899

    CAS  PubMed  Google Scholar 

  • Schneider EM, Dorries K (1993) High frequency of polyomavirus infection in lymphoid cell preparations after allogeneic bone marrow transplantation. Transplant Proc 25:1271–1273

    CAS  PubMed  Google Scholar 

  • Schon MP (2008) Efalizumab in the treatment of psoriasis: mode of action, clinical indications, efficacy, and safety. Clin Dermatol 26:509–514

    PubMed  Google Scholar 

  • Schuna AA (2007) Rituximab for the treatment of rheumatoid arthritis. Pharmacotherapy 27:1702–1710

    CAS  PubMed  Google Scholar 

  • Seif I, Khoury G, Dhar R (1979) The genome of human papovavirus BKV. Cell 18:963–977

    CAS  PubMed  Google Scholar 

  • Seong D, Bruner JM, Lee KH, Mirza N, Kwon BD, Lee JH, Lee YY, Ro J, Talpaz M, Champlin R et al (1996) Progressive multifocal leukoencephalopathy after autologous bone marrow transplantation in a patient with chronic myelogenous leukemia. Clin Infect Dis 23:402–403

    CAS  PubMed  Google Scholar 

  • Seth P, Diaz F, Tao-Cheng JH, Major EO (2004) JC virus induces nonapoptotic cell death of human central nervous system progenitor cell-derived astrocytes. J Virol 78:4884–4891

    CAS  PubMed  Google Scholar 

  • Sharma AK, Kumar G (1991) A 53 kDa protein binds to the negative regulatory region of JC virus early promoter. FEBS Lett 281:272–274

    CAS  PubMed  Google Scholar 

  • Shinohara T, Nagashima K, Major EO (1997) Propagation of the human polyomavirus, JCV, in human neuroblastoma cell lines. Virology 228:269–277

    CAS  PubMed  Google Scholar 

  • Shivakumar CV, Das GC (1994) Biochemical and mutational analysis of the polyomavirus core promoter: involvement of nuclear factor-1 in early promoter function. J Gen Virol 75(Pt 6):1281–1290

    CAS  PubMed  Google Scholar 

  • Singer EJ, Stoner GL, Singer P, Tomiyasu U, Licht E, Fahy-Chandon B, Tourtellotte WW (1994) AIDS presenting as progressive multifocal leukoencephalopathy with clinical response to zidovudine. Acta Neurol Scand 90:443–447

    CAS  PubMed  Google Scholar 

  • Smith CR, Sima AA, Salit IE, Gentili F (1982) Progressive multifocal leukoencephalopathy: failure of cytarabine therapy. Neurology 32:200–203

    CAS  PubMed  Google Scholar 

  • Sobell JM, Weinberg JM (2009) Patient fatalities potentially associated with efalizumab use. J Drugs Dermatol 8:215

    PubMed  Google Scholar 

  • Sock E, Enderich J, Wegner M (1999) The J domain of papovaviral large tumor antigen is required for synergistic interaction with the POU-domain protein Tst-1/Oct6/SCIP. Mol Cell Biol 19:2455–2464

    CAS  PubMed  Google Scholar 

  • Soulas-Sprauel P, Rivera-Munoz P, Malivert L, Le Guyader G, Abramowski V, Revy P, de Villartay JP (2007) V(D)J and immunoglobulin class switch recombinations: a paradigm to study the regulation of DNA end-joining. Oncogene 26:7780–7791

    CAS  PubMed  Google Scholar 

  • Steiger MJ, Tarnesby G, Gabe S, McLaughlin J, Schapira AH (1993) Successful outcome of progressive multifocal leukoencephalopathy with cytarabine and interferon. Ann Neurol 33:407–411

    CAS  PubMed  Google Scholar 

  • Stieglbauer K, Topakian R, Schaffer V, Aichner FT (2009) Rituximab for myasthenia gravis: three case reports and review of the literature. J Neurol Sci 280:120–122

    CAS  PubMed  Google Scholar 

  • Sumner C, Shinohara T, Durham L, Traub R, Major EO, Amemiya K (1996) Expression of multiple classes of the nuclear factor-1 family in the developing human brain: differential expression of two classes of NF-1 genes. J Neurovirology 2:87–100

    CAS  Google Scholar 

  • Sunden Y, Semba S, Suzuki T, Okada Y, Orba Y, Nagashima K, Umemura T, Sawa H (2007a) DDX1 promotes proliferation of the JC virus through transactivation of its promoter. Microbiol Immunol 51:339–347

    CAS  PubMed  Google Scholar 

  • Sunden Y, Semba S, Suzuki T, Okada Y, Orba Y, Nagashima K, Umemura T, Sawa H (2007b) Identification of DDX1 as a JC virus transcriptional control region-binding protein. Microbiol Immunol 51:327–337

    CAS  PubMed  Google Scholar 

  • Swamy PA, Nardino R (2003) Progressive multifocal leukoencephalopathy in a patient with chronic myelogenous leukemia. Conn Med 67:263–264

    PubMed  Google Scholar 

  • Tada H, Khalili K (1992) A novel sequence-specific DNA-binding protein, LCP-1, interacts with single-stranded DNA and differentially regulates early gene expression of the human neurotropic JC virus. J Virol 66:6885–6892

    CAS  PubMed  Google Scholar 

  • Tamura T, Inoue T, Nagata K, Mikoshiba K (1988) Enhancer of human polyoma JC virus contains nuclear factor I-binding sequences; analysis using mouse brain nuclear extracts. Biochem Biophys Res Commun 157:419–425

    CAS  PubMed  Google Scholar 

  • Tan C, Dezube B, Bhargava P, Autissier P, Wuthrich C, Miller J, Koralnik IJ (2009) Detection of JC virus DNA and proteins in the bone marrow of HIV-positive and HIV-negative patients: implications for viral latency and neurotropic transformation. J Infect Dis 199:881–888

    PubMed  Google Scholar 

  • Tashiro K, Doi S, Moriwaka F, Maruo Y, Nomura M (1987) Progressive multifocal leucoencephalopathy with magnetic resonance imaging verification and therapeutic trials with interferon. J Neurol 234:427–429

    CAS  PubMed  Google Scholar 

  • Terrier B, Hummel A, Fakhouri F, Jablonski M, Hugle T, Gasnault J, Sanson M, Martinez F (2007) Progressive multifocal leukoencephalopathy in a non-AIDS patient: high efficiency of combined cytarabine and cidofovir. Rev Med Interne 28:488–491

    CAS  PubMed  Google Scholar 

  • Toovey S (2009) Mefloquine neurotoxicity: a literature review. Travel Med Infect Dis 7:2–6

    PubMed  Google Scholar 

  • Tornatore C, Berger JR, Houff SA, Curfman B, Meyers K, Winfield D, Major EO (1992) Detection of JC virus DNA in peripheral lymphocytes from patients with and without progressive multifocal leukoencephalopathy. Ann Neurol 31:454–462

    CAS  PubMed  Google Scholar 

  • Tubridy N, Wells C, Lewis D, Schon F (2000) Unsuccessful treatment with cidofovir and cytarabine in progressive multifocal leukoencephalopathy associated with dermatomyositis. J R Soc Med 93:374–375

    CAS  PubMed  Google Scholar 

  • Vacante DA, Traub R, Major EO (1989) Extension of JC virus host range to monkey cells by insertion of a simian virus 40 enhancer into the JC virus regulatory region. Virology 170:353–361

    CAS  PubMed  Google Scholar 

  • Van Assche G, Van Ranst M, Sciot R, Dubois B, Vermeire S, Noman M, Verbeeck J, Geboes K, Robberecht W, Rutgeerts P (2005) Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn’s disease. N Engl J Med 353:362–368

    PubMed  Google Scholar 

  • Vaz B, Cinque P, Pickhardt M, Weber T (2000) Analysis of the transcriptional control region in progressive multifocal leukoencephalopathy. J Neurovirology 6:398–409

    CAS  Google Scholar 

  • Vulliemoz S, Lurati-Ruiz F, Borruat FX, Delavelle J, Koralnik IJ, Kuntzer T, Bogousslavsky J, Picard F, Landis T, Du Pasquier RA (2006) Favourable outcome of progressive multifocal leucoencephalopathy in two patients with dermatomyositis. J Neurol Neurosurg Psychiatry 77:1079–1082

    CAS  PubMed  Google Scholar 

  • Wenning W, Haghikia A, Laubenberger J, Clifford DB, Behrens PF, Chan A, Gold R (2009) Treatment of progressive multifocal leukoencephalopathy associated with natalizumab. N Engl J Med 361:1075–1080

    CAS  PubMed  Google Scholar 

  • White MK, Johnson EM, Khalili K (2009) Multiple roles for Puralpha in cellular and viral regulation. Cell Cycle 8:1–7

    PubMed  Google Scholar 

  • Wingerchuk DM, Weinshenker BG (2005) Neuromyelitis optica. Curr Treat Options Neurol 7:173–182

    PubMed  Google Scholar 

  • Yamamoto M, Kaneko K, Ohta K, Ogura Y, Ueda Y, Tazima M, Takeda F (1987) Progressive multifocal leukoencephalopathy in a child with acute lymphocytic leukemia. Rinsho Ketsueki 28:541–546

    CAS  PubMed  Google Scholar 

  • Yang RC, Wu R (1979) Comparative study of papovavirus DNA: BKV(MM), BKV(WT) and SV40. Nucleic Acids Res 7:651–668

    CAS  PubMed  Google Scholar 

  • Yogo Y, Kitamura T, Sugimoto C, Ueki T, Aso Y, Hara K, Taguchi F (1990) Isolation of a possible archetypal JC virus DNA sequence from nonimmunocompromised individuals. J Virol 64:3139–3143

    CAS  PubMed  Google Scholar 

  • Yokoyama H, Watanabe T, Maruyama D, Kim SW, Kobayashi Y, Tobinai K (2008) Progressive multifocal leukoencephalopathy in a patient with B-cell lymphoma during rituximab-containing chemotherapy: case report and review of the literature. Int J Hematol 88:443–447

    PubMed  Google Scholar 

  • Zohren F, Toutzaris D, Klarner V, Hartung HP, Kieseier B, Haas R (2008) The monoclonal anti-VLA-4 antibody natalizumab mobilizes CD34+ hematopoietic progenitor cells in humans. Blood 111:3893–3895

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory of Molecular Medicine and Neuroscience, Molecular Medicine and Virology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, 10 Center Drive, Building 10 Room 3B14 MSC 1295, Bethesda, MD, 20892-1296, USA

    Leslie J. Marshall & Eugene O. Major

Authors
  1. Leslie J. Marshall
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eugene O. Major
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Leslie J. Marshall.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Marshall, L.J., Major, E.O. Molecular Regulation of JC Virus Tropism: Insights into Potential Therapeutic Targets for Progressive Multifocal Leukoencephalopathy. J Neuroimmune Pharmacol 5, 404–417 (2010). https://doi.org/10.1007/s11481-010-9203-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11481-010-9203-1

Keywords

Search

Navigation